Table 4.
Change in Cardiometabolic Risk Factors in Participants With Type 2 Diabetes Who Completed HDRP (n = 34).
| Risk factor | Baseline mean (SD) | 1-month mean (SD) | Difference at 1 month (P-value) | Post-treatment mean (SD) | Difference at post treatment (P-value) |
|---|---|---|---|---|---|
| Body weight (lbs.) | 218.0 (40.60) | 210.5 (39.25) | −7.44 (0.49) | 206.5 (37.42) | −11.44 (0.24) |
| BMI (kg/m2) | 32.22 (6.09) | 31.23 (5.56) | −0.99 (0.53) | 31.32 (7.74) | −0.91 (0.60) |
| Waist circumference (inches) | 45.48 (6.06) | 44.5 (5.90) | −0.98 (0.60) | 42.08 (5.33) | −3.40 (0.052) |
| Systolic blood pressure (mmHg) | 135.5 (21.24) | 130.0 (18.92) | −5.48 (0.36) | 124.5 (12.44) | −10.98* (0.01) |
| Diastolic blood pressure (mmHg) | 71.33 (13.94) | 64.94 (11.06) | −6.39 (0.09) | 64.69 (10.40) | −6.65* (0.03) |
| Pulse (beats per minute) | 67.21 (11.58) | 64.55 (14.58) | −2.66 (0.55) | 63.78 (10.80 | −3.42 (0.28) |
| TC (mg/dL) | 122.3 (33.36) | 108.9 (27.87) | −13.44 (0.11) | 114.9 (33.45) | −7.45 (0.38) |
| LDL-C (mg/dL) | 59.87 (27.11) | 46.92 (26.14) | −12.95 (0.07) | 50.07 (20.68) | −9.80 (0.12) |
| HDL-C (mg/dL) | 36.94 (10.10) | 36.61 (16.74) | −0.32 (0.92) | 38.45 (13.21) | 1.52 (0.61) |
| Triglycerides (mg/dL) | 130.6 (69.45) | 143.2 (74.24) | 12.61 (0.51) | 128.6 (101.7) | −1.94 (0.93) |
| Fasting glucose (mg/dL) | 147.1 (46.71) | 141.4 (49.99) | −5.75 (0.66) | 129.2 (46.56) | −17.88 (0.12) |
| Hemoglobin A1C (%) | 7.64 (1.30) | 7.22 (1.26) | −0.42 (0.31) | 6.84 (1.03) | −0.80** (0.007) |
| CRP (mg/L) | 2.77 (2.88) | 1.62 (1.79) | −1.14 (0.13) | 1.82 (2.14) | −0.95 (0.16) |
Note. TC, total cholesterol, LDL-C, low density lipoprotein-cholesterol, HDL-C, high density lipoprotein-cholesterol, CRP, C-reactive protein, *P < 0.05, **P < 0.01.